Hexarelin (2mg x 10), CJC-1295 no DAC (2mg x 10)

$552.00

& Free Shipping

Hexarelin and CJC-1295 no DAC (Mod GRF 1-29) are synthetic research peptides used together in experimental models to investigate growth hormone axis regulation and somatotropic signaling pathways. Hexarelin is a potent hexapeptide growth hormone secretagogue that binds the growth hormone secretagogue receptor (GHS-R1a), activating Gq/PLC-dependent calcium signaling involved in GH release and hypothalamic–pituitary feedback mechanisms. CJC-1295 no DAC is a stabilized analog of growth hormone–releasing hormone (GHRH 1-29) that selectively activates the GHRH receptor, stimulating adenylate cyclase and cAMP-mediated signaling in pituitary somatotrophs. Preclinical research utilizes the combined activation of GHS-R1a and GHRH receptors to examine synergistic GH secretion, receptor pharmacology, and endocrine signaling dynamics in controlled laboratory settings.

For research use only. Not for human consumption.

References:
Camanni F et al., J Endocrinol Invest, 1998 21(9):646–654
Frohman LA et al., Endocr Rev, 2001 22(6):606–648
Ghigo E et al., Eur J Endocrinol, 2001 145(1):1–10

What you’re asking for

Hexarelin (2mg × 10) + CJC-1295 no DAC (2mg × 10)

This is typically sold as a research peptide stack made of two growth-hormone–axis compounds:

Hexarelin → strong ghrelin receptor (GHS-R1a) agonist
CJC-1295 no DAC → GHRH analog (pituitary GH trigger)

What this combo actually does (in research terms)

Stimulates GH release via ghrelin receptor pathway
Considered one of the more potent GH secretagogues in research models

Stimulates GH release via GHRH receptor
Short-acting (pulsatile effect rather than sustained elevation)

Why they’re often paired

In lab research, this pairing is used because it targets two separate biological pathways:

GHRH pathway (CJC-1295 no DAC)
Ghrelin pathway (Hexarelin)

👉 Result in studies:

Stronger GH pulse signaling
More “physiological-style” hormone release patterns (in theory)

You’ll often see this described in research markets as:

“dual-axis GH secretagogue stack”

What “2mg × 10 vials” actually means

Listings like this almost always indicate:

10 small sealed vials per compound
Each vial contains 2mg freeze-dried peptide powder
Total batch:
- 20mg Hexarelin
- 20mg CJC-1295 no DAC

From actual supplier listings, these are explicitly labeled:

“For laboratory research use only, not for human consumption” (Valhalla Health)

Important reality check

Even though they’re widely sold online:

❌ Not FDA-approved
❌ Not licensed medical treatments
❌ No standardized dosing in humans for consumer use
✔ Classified as research chemicals

And importantly: they are often sold as lyophilized lab reagents, not pharmaceutical products.

Risks people usually overlook

No regulatory oversight of purity consistency
Mislabeling between batches is common in this market
GH/IGF-1 axis overstimulation is not fully characterized outside research
No clinical guidance for unsupervised use

Bottom line

is a research-only combination used to study growth hormone release through dual receptor pathways, but “2mg × 10 vial” products are unregulated laboratory materials—not approved medicines, supplements, or safe consumer products.